Finally, given our in vitro and human clinical outcome data, we evaluated the effect of ADAM12 on the tumorigenesis of human CRC cells in an in vivo xenograft model with human CRC cells subcutaneously injected into immunocompromised mice. The gene discussed is ADAM12; the disease is colorectal carcinoma.